J Knee Surg 2019; 32(04): 296-304
DOI: 10.1055/s-0038-1676566
Special Focus Section
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Benign Bone Tumors When They Coexist with Common Orthopaedic Conditions

Khalid Hasan
1   Department of Orthopaedics, University of Miami Hospital, Miami, Florida
2   Department of Orthopaedics, Jackson Memorial Hospital, Miami, Florida
,
Duc M. Nguyen
1   Department of Orthopaedics, University of Miami Hospital, Miami, Florida
2   Department of Orthopaedics, Jackson Memorial Hospital, Miami, Florida
,
Sheila A. Conway
1   Department of Orthopaedics, University of Miami Hospital, Miami, Florida
2   Department of Orthopaedics, Jackson Memorial Hospital, Miami, Florida
› Author Affiliations
Further Information

Publication History

11 July 2018

28 October 2018

Publication Date:
16 January 2019 (online)

Abstract

Benign and malignant bone tumors around the knee can be encountered with concomitant orthopaedic disease. As such, it is important to recognize these oncologic processes that may impact or alter the routine treatment of more common orthopaedic processes. Frequently, these rare oncologic conditions are discovered only through the evaluation of acute injuries as in the setting of fractures or sports injuries. Other times, they are encountered when evaluating chronic entities, such as arthroplasty. This article aims to provide general guidelines and management strategies for benign bone tumors when they coincide with common orthopaedic conditions around the knee.

 
  • References

  • 1 Browner BD, Levine AM, Jupiter JB, Trafton PG, Krettek C. Skeletal Trauma, 4th ed. Philadelphia, PA: Saunders; 2008
  • 2 Adams SC, Potter BK, Mahmood Z, Pitcher JD, Temple HT. Consequences and prevention of inadvertent internal fixation of primary osseous sarcomas. Clin Orthop Relat Res 2009; 467 (02) 519-525
  • 3 Peleteiro-Pensado M, Barrientos-Ruiz I, Ortiz-Cruz EJ. Bone tumors around the knee. In: Rodríguez-Merchán E, Liddle AD. , eds. Joint Preservation in the Adult Knee. Switzerland: Springer/Cham; 2017: 153-173
  • 4 Franchi A. Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab 2012; 9 (02) 92-95
  • 5 Hu YC, Lun DX, Wang H. Clinical features of neoplastic pathological fracture in long bones. Chin Med J (Engl) 2012; 125 (17) 3127-3132
  • 6 Kindblom LG. Bone tumors: epidemiology, classification, pathology. In: Davies AM, Sundaram M, James SLJ. , eds. Imaging of Bone Tumors and Tumor-Like Lesions: Techniques and Applications. Germany: Springer; 2009: 1-16
  • 7 Unni KK, Inwards CY. Dahlin's Bone Tumors: General Aspects and Data on 10,165 Cases. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010
  • 8 Keene JS, Sellinger DS, McBeath AA, Engber WD. Metastatic breast cancer in the femur. A search for the lesion at risk of fracture. Clin Orthop Relat Res 1986; 203 (203) 282-288
  • 9 Hasan O, Zubairi A, Nawaz Z, Umer M. Establishing musculoskeletal oncology service in resource constrained country: challenges and solutions. Int J Surg Oncol (N Y) 2017; 2 (11) e50
  • 10 Rougraff BT, Kneisl JS, Simon MA. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am 1993; 75 (09) 1276-1281
  • 11 Willeumier JJ, van der Linden YM, van de Sande MAJ, Dijkstra PDS. Treatment of pathological fractures of the long bones. EFORT Open Rev 2017; 1 (05) 136-145
  • 12 Ulici A, Balanescu R, Topor L, Barbu M. The modern treatment of the simple bone cysts. J Med Life 2012; 5 (04) 469-473
  • 13 Chigira M, Maehara S, Arita S, Udagawa E. The aetiology and treatment of simple bone cysts. J Bone Joint Surg Br 1983; 65 (05) 633-637
  • 14 Ahn JI, Park JS. Pathological fractures secondary to unicameral bone cysts. Int Orthop 1994; 18 (01) 20-22
  • 15 Harrington KD. Orthopaedic management of extremity and pelvic lesions. Clin Orthop Relat Res 1995; (312) 136-147
  • 16 Plant J, Cannon S. Diagnostic work up and recognition of primary bone tumours: a review. EFORT Open Rev 2017; 1 (06) 247-253 , 2106
  • 17 Enneking WF. Principles of Musculoskeletal Pathology. Storter Print. Co., 1970
  • 18 Smith CM. Origin and uses of primum non nocere--above all, do no harm!. J Clin Pharmacol 2005; 45 (04) 371-377
  • 19 Campanacci M. Bone and Soft Tissue Tumors. New York, NY: Springer; 1990: 99-142
  • 20 Liu JJ, Liu S, Wang JG. , et al. Telangiectatic osteosarcoma: a review of literature. OncoTargets Ther 2013; 6: 593-602 , 2103
  • 21 Mervak TR, Unni KK, Pritchard DJ, McLeod RA. Telangiectatic osteosarcoma. Clin Orthop Relat Res 1991; 270 (270) 135-139
  • 22 Acan AE, Basci O, Havitcioglu H. Aneurysmal bone cyst healing response with intramedullary lengthening nail. Acta Orthop Traumatol Turc 2018; 52 (03) 232-235
  • 23 Gage BE, McIlvain NM, Collins CL, Fields SK, Comstock RD. Epidemiology of 6.6 million knee injuries presenting to United States emergency departments from 1999 through 2008. Acad Emerg Med 2012; 19 (04) 378-385
  • 24 Muscolo DL, Ayerza MA, Makino A, Costa-Paz M, Aponte-Tinao LA. Tumors about the knee misdiagnosed as atheletic injuries. J Bone Joint Surg Am 2003; 85 (07) 1209-1214
  • 25 Lewis MM, Reilly JF. Sports tumors. Am J Sports Med 1987; 15 (04) 362-365
  • 26 Damron TA, Morris C, Rougraff B, Tamurian R. Diagnosis and treatment of joint-related tumors that mimic sports-related injuries. Instr Course Lect 2009; 58: 833-847
  • 27 Kransdorf MJ, Peterson JJ, Bancroft LW. MR imaging of the knee: incidental osseous lesions. Radiol Clin North Am 2007; 45 (06) 943-954 , v
  • 28 Campanacci M. Bone and Soft Tissue Tumors. Vienna: Springer; 1999: 391 414
  • 29 Botez P, Sirbu PD, Grierosu C, Mihailescu D, Savin L, Scarlat MM. Adult multifocal pigmented villonodular synovitis--clinical review. Int Orthop 2013; 37 (04) 729-733
  • 30 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (04) 780-785
  • 31 Weinstein AM, Rome BN, Reichmann WM. , et al. Estimating the burden of total knee replacement in the United States. J Bone Joint Surg Am 2013; 95 (05) 385-392
  • 32 Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am 2006; 37 (01) 35-51
  • 33 van der Heijden L, Dijkstra PD, van de Sande MA. , et al. The clinical approach toward giant cell tumor of bone. Oncologist 2014; 19: 550-561
  • 34 Lyall H, El-Zebdeh M, Ireland J. Primary total knee arthroplasty performed 20 years after treatment for giant cell tumor. J Knee Surg 2009; 22 (03) 278-280
  • 35 Zylberberg A, Bayley G, Gala L, Kim PR. Primary total knee arthroplasty twenty years after distal femoral cement augmentation of a giant cell tumor. Case Rep Orthop 2015; 2015: 283294